Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food …